Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:37 PM
Ignite Modification Date:
2025-12-24 @ 6:37 PM
NCT ID:
NCT00004757
Eligibility Criteria:
PROTOCOL ENTRY CRITERIA:
--Disease Characteristics--
* Virologically confirmed herpes simplex virus type 2 (HSV-2) with skin lesions localized to the skin, eyes, and mouth
* No central nervous system or disseminated disease Normal cerebrospinal fluid WBC less than 20 Protein less than 90 mg/dL
* Normal brain computerized tomography or magnetic resonance imaging (MRI) MRI if feasible
* No HSV-1
--Patient Characteristics--
* Age: Under 29 days
* Renal: Creatinine no greater than 1.5 mg/dL
* Other: Birth weight at least 1200 g
* Gestational age greater than 32 weeks
* No breast feeding if mother on acyclovir
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
0 Years
Maximum Age:
29 Days
Study:
NCT00004757
Study Brief:
Protocol Section:
NCT00004757